1. Transcriptional profiling reveals distinct classes of parathyroid tumors in PHPT
   James Koh et al, 2018, Endocrine-Related Cancer CrossRef
2. Overexpression of teneurin transmembrane protein 1 is a potential marker of disease progression in papillary thyroid carcinoma
   Shih-Ping Cheng et al, 2017, Clinical and Experimental Medicine CrossRef
3. Comparative proteomic analysis of chief and oxyphil cell nodules in refractory uremic hyperparathyroidism by iTRAQ coupled LC-MS/MS
   Shensen Li et al, 2018, Journal of Proteomics CrossRef
4. Transcriptome analysis of papillary thyroid cancer harboring telomerase reverse transcriptase promoter mutation
   Ming‐Nan Chien et al, 2018, Head & Neck CrossRef
5. Inhibition of 3β-Hydroxysteroid Dehydrogenase Type 1 Suppresses Interleukin-6 in Breast Cancer
   Yuan-Ching Chang et al, 2019, Journal of Surgical Research CrossRef
6. Computational drug repurposing for primary hyperparathyroidism
   Elif Kubat Öktem et al, 2024, Molecular and Cellular Endocrinology CrossRef
7. Primary hyperparathyroidism characterized by diffuse homogeneous metastatic pulmonary calcification
   Yuzhu Jia et al, 2018, Medicine CrossRef
8. Recurrence-associated genes in papillary thyroid cancer: An analysis of data from The Cancer Genome Atlas
   Ming-Nan Chien et al, 2017, Surgery CrossRef
9. Symptomatic primary hyperparathyroidism in a young woman presenting with multiple skeletal destructions: a case report and review of literature
   Shuai Lu et al, 2021, BMC Endocrine Disorders CrossRef